-+ 0.00%
-+ 0.00%
-+ 0.00%
The sword refers to the scarce A-share AI4S target! Jietai Technology (07666) returns to A to release confidence in long-term development
Share
Listen to the news

The Zhitong Finance App learned that on November 18, Jietai Technology (07666) issued an announcement stating that in order to promote business development and enhance overall competitive strength, the company plans to begin issuing common shares (A shares) denominated in RMB and the listing of such shares. The Board of Directors has resolved and approved the commencement of relevant preparations.

This return to the A layout sends a positive signal from management about the company's future business development and long-term value. For a technology company focusing on AI-driven drug development, entering the A-share market is expected to further increase its attention in the domestic capital market and open up a wider space for value discovery for the company.

Judging from the capitalization basis, Jietai Technology has previously completed the dismantling of the red chip structure. If the A-share listing is further promoted, the company will have the opportunity to enter a stricter system of performance verification, financial regulations and information disclosure. Financial standards, internal control, use of funds raised, and related transactions will all be subject to stricter external inspections. In the long run, it will help improve the level of corporate governance and operational transparency, and enhance institutional investors' recognition of the company.

At the same time, the market is also concerned about Jietai Technology's potential A-share listing standards. According to current market analysis, the company may consider applying the relevant listing standards of the Shanghai Stock Exchange in the future, of which the second and fourth sets of standards will probably be applied. Although the specific listing sector and applicable standards have yet to be further clarified by the company, the company's push back to A related arrangement at this time also shows management's confidence in future business performance and performance growth to a certain extent.
Judging from the industry positioning, the scarcity of Jietai Technology is also worth paying attention to. The company focuses on the field of AI4S (Artificial Intelligence Driven Scientific Research), combines artificial intelligence technology with drug development, and explores the use of AI to improve drug discovery and development efficiency. If Jietai Technology successfully lands on A-shares in the future, it is expected to become the first AI4S listed company in the A-share market.

Furthermore, with regard to the issue of lifting the ban on cornerstone investors that the market is concerned about, return A itself involves various steps such as board decisions, intermediary agency recruitment, audits and internal control regulations, and guidance and filing. The entire preparation process takes a long time, and should not simply be equated with short-term stock price fluctuations or pressure on cornerstone investors to lift the ban.

Overall, the management of Jietai Technology announced a push back to A at this point, which shows that the company's management is determined to persist in long-term development. As the AI4S industrialization process continues to advance, if the company can use the capital market platform to accelerate technology research and development, commercialization and business expansion, it is expected that its long-term growth space and capital market value will be further explored.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending